Thomas R. Kuhn - 20 May 2026 Form 4 Insider Report for Anterix Inc. (ATEX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Aug 2026, 16:46:41 UTC
Prior SEC filing
16 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
s/ Gena L. Ashe, Attorney-in-Fact

Key filing fact

Thomas R. Kuhn filed Form 4 for Anterix Inc. (ATEX) on 26 Aug 2026.

Key facts

  • This page summarizes Thomas R. Kuhn's Form 4 filing for Anterix Inc. (ATEX).
  • 8 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 26 Aug 2026, 16:46.

Change

  • Previous filing in this sequence was filed on 16 Jun 2025.
  • Current net transaction value: -$1,020,053.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001571521 Primary reporting owner

Kuhn Thomas R.

Relationship
Director, Executive Chairman
Address
3 GARRET MOUNTAIN PLAZA SUITE 401, WOODLAND PARK
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Signature date
26 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATEX transaction

Common Stock

Award

Transaction value
Shares
+2,791
Change %
+17%
Price
Shares after
19,385
Date
20 May 2026
Ownership
Direct
Footnotes
F1
ATEX transaction

Common Stock

Sale

Transaction value
$131,526
Shares
-1,654
Change %
-8.5%
Price
$79.52
Shares after
17,731
Date
18 Jun 2026
Ownership
Direct
Footnotes
F2
ATEX transaction

Common Stock

Options Exercise

Transaction value
Shares
+10,000
Change %
+56%
Price
$33.62*
Shares after
27,731
Date
24 Aug 2026
Ownership
Direct
ATEX transaction

Common Stock

Sale

Transaction value
$387,295
Shares
-4,392
Change %
-16%
Price
$88.18
Shares after
23,339
Date
24 Aug 2026
Ownership
Direct
Footnotes
F3
ATEX transaction

Common Stock

Sale

Transaction value
$393,726
Shares
-4,418
Change %
-19%
Price
$89.12
Shares after
18,921
Date
24 Aug 2026
Ownership
Direct
Footnotes
F4
ATEX transaction

Common Stock

Sale

Transaction value
$71,101
Shares
-790
Change %
-4.2%
Price
$90.00
Shares after
18,131
Date
24 Aug 2026
Ownership
Direct
Footnotes
F5
ATEX transaction

Common Stock

Sale

Transaction value
$36,404
Shares
-400
Change %
-2.2%
Price
$91.01
Shares after
17,731
Date
24 Aug 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATEX transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-10,000
Change %
-17%
Price
$0.000000*
Shares after
48,998
Date
24 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,000
Exercise price
$33.62
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock. The RSU vests in full on the earlier of: (i) May 20, 2027, and (ii) the Issuer's next annual stockholder meeting.

Footnote F2

These shares of Common Stock were automatically sold in a non-discretionary transaction to cover tax withholding obligations upon the settlement of certain time-based RSU awards.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.67 to $88.66, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.71 to $89.67, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.79 to $90.51, inclusive. The Reporting Person has provided to the Issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F6

1/3rd of the option shares vest and become exercisable on January 2, 2025, with the remaining option shares vesting in two equal annual installments thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .